InvestorsHub Logo
Followers 8
Posts 307
Boards Moderated 0
Alias Born 08/14/2010

Re: BiotechValues post# 77224

Thursday, 03/31/2011 5:30:38 PM

Thursday, March 31, 2011 5:30:38 PM

Post# of 94785
SPU-You are looking at this completely wrong.

Q4 eps down 16% with a 24% increase in shares...OK...really not good at all...dare I say BAD



Q4 EPS was only weak, when compared QoverQ, because of the issuance of shares. Full year EPS, adjusting for warrant liability charges, was 1.01 (20% YOY growth). So its at 4.36x for a company generally regarded as legitimate, and that won't be diluting anytime soon (look at CAPEX estimates). The only reason margins declined was because of their change in product mix away from kiwi's(Rev decreased 7%) and into apple's (Rev grew 287%), which I like for diversification.


I'm long
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.